GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly Top Insider Buys: BAC, CSCO, GM, VRX, SPLS

June 05, 2011 | About:
gururk

gururk

7 followers
Weekly highlight of top insider buys: Bank of America Corp. (BAC), Cisco Systems Inc. (CSCO), General Motors Company (GM), Valeant Pharmaceuticals International (VRX) and Staples Inc. (SPLS).

Bank of America Corp. (BAC): Director Charles O. Rossotti Bought 20,000 Shares

Director of Bank of America Corp., Charles O. Rossotti, bought 20,000 shares on 5/27/2011 at an average price of $11.28. Bank of America Corp. is one of the world's financial services companies. Bank Of America Corp. has a market cap of $114.29 billion; its shares were traded at around $11.28 with a P/E ratio of 15.1 and P/S ratio of 0.9. The dividend yield of Bank Of America Corp. stocks is 0.3%.

On April 15, Bank of America Corporation reported net income of $2.0 billion, or $0.17 per diluted share, for the first quarter of 2011, compared with $3.2 billion, or $0.28 per diluted share, in the year-ago period and a net loss of $1.2 billion, or $0.16 per diluted share, in the fourth quarter of 2010. Results for the most recent quarter were positively affected by lower credit costs, gains from equity investments, and higher asset management fees and investment banking fees. These factors were partially offset by higher legacy mortgage-related costs, higher litigation expenses, and lower sales and trading revenue from the record levels reported in the first quarter of 2010.

Bank of America Corp. is in the portfolios of Kenneth Fisher, Richard Snow, James Barrow, Michael Price, Chris Davis, Richard Pzena, Bruce Berkowitz, Bill Nygren, John Paulson, Brian Rogers, David Dreman, Irving Kahn, Dodge & Cox, Charles Brandes, Mark Hillman, David Tepper, Ruane Cunniff, John Keeley, Mario Gabelli, and George Soros.

Last month, Buy: Director Charles O. Rossotti bought 20,000 shares of Bank of America stock.

Cisco Systems Inc. (CSCO): Director Steven M. West Bought 3,700 Shares

Director of Cisco Systems Inc., Steven M. West, bought 3,700 shares on 5/26/2011 at an average price of $16.01.

Cisco Systems Inc. is the worldwide leader in networking for the Internet. Cisco Systems Inc. has a market cap of $88.5 billion; its shares were traded at around $16.01 with a P/E ratio of 11.1 and P/S ratio of 2.2. The dividend yield of Cisco Systems Inc. stocks is 1.4%. Cisco Systems Inc. had an annual average earnings growth of 23% over the past 10 years. GuruFocus rated Cisco Systems Inc. the business predictability rank of 2.5-star.

Cisco Systems Inc. is in the portfolios of Bruce Berkowitz, Tweedy Browne, Arnold Schneider, David Dreman, Arnold Van Den Berg, Mark Hillman, Donald Yacktman, Whitney Tilson, Jean-Marie Eveillard, Private Capital, Edward Lampert, George Soros, Kenneth Fisher, Brian Rogers, Joel Greenblatt, PRIMECAP Management, Bill Nygren, Richard Perry, Ronald Muhlenkamp, Robert Olstein, John Hussman, and Richard Snow.

On November 10, Cisco reported its first quarter results for the period ended October 30, 2010. Cisco reported first-quarter net sales of $10.75 billion, net income on a generally accepted accounting principles (GAAP) basis of $1.9 billion or $0.34 per share, and non-GAAP net income of $2.4 billion or $0.42 per share.

Last month, Buy: Director Steven M. West bought 3,700 shares of CSCO stock. Sell: SVP, LglSrvs, GenCnsl & Secty Mark D. Chandler sold 30,000 shares in April. Sell: Director Larry R. Carter Sell: EVP, Chief Globalisation Ofr Wim Elfrink sold shares in March.

General Motors Company (GM): Director E. Neville Isdell Bought 8,000 Shares

Director of General Motors Company, E. Neville Isdell, bought 8,000 shares on 05/26/2011 at an average price of $29.12. General Motors Company is engaged in the designing, manufacturing and retailing of vehicles globally including passenger cars, crossover vehicles and light trucks, sport utility vehicles, vans and other vehicles. General Motors Company has a market cap of $45.45 billion; its shares were traded at around $29.12 with and P/S ratio of 0.4.

General Motors Company is in the portfolios of Richard Perry, NWQ Managers, Mario Gabelli, Arnold Schneider, Brian Rogers, Third Avenue Management, and George Soros.

On May 5, General Motors Company announced first-quarter net income attributable to common stockholders of $3.2 billion, or $1.77 per fully-diluted share, marking the company’s fifth consecutive profitable quarter. Revenue increased $4.7 billion to $36.2 billion, compared with the first quarter of 2010.

Last month, Buy: CEO Daniel F. Akerson and Buy: Director E. Neville Isdell bought shares of GM stock. Buy: Director Robert D. Krebs and Buy: Director Philip A. Laskawy bought shares in March.

Valeant Pharmaceuticals International (VRX): EVP, GC & Corp. Sec. Robert Roswell Chai-onn Bought 10,000 Shares

EVP, GC & Corp. Sec. of Valeant Pharmaceuticals International, Robert Roswell Chai-onn, bought 10,000 shares on 5/27/2011 at an average price of $53.45. Valeant Pharmaceuticals International Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International has a market cap of $16.26 billion; its shares were traded at around $53.45 with a P/E ratio of 51 and P/S ratio of 13.7.

On May 9, Valeant Pharmaceuticals Inc. reported total revenue was $565.0 million in the first quarter of 2011 as compared to $219.6 million in the first quarter of 2010. Included in total revenue was $36.0 million of alliance and royalty revenue related to the out-license of product rights for Cloderm, a mid-potency steroid with an annual revenue run rate of approximately $7 million, that was completed on March 31, 2011.

Valeant Pharmaceuticals International is in the portfolios of Glenn Greenberg, John Griffin, Ruane Cunniff, Private Capital, Jean-Marie Eveillard, Julian Robertson, Andreas Halvorsen, John Hussman, and NWQ Managers.

Last month, Buy: EVP, GC & Corp. Sec. Robert Roswell Chai-onn and Buy: Director Norma Ann Provencio bought shares of VRX stock. Buy: Director Katharine Berghuis Stevenson and Buy: Director Norma Ann Provencio bought shares in March. Sell: Holdings, L.p. Valueact sold 4,498,180 shares in March.

Staples Inc. (SPLS): Director Robert E. Sulentic Bought 15,150 Shares

Director of Staples Inc., Robert E. Sulentic, bought 15,150 shares on 5/26/2011 at an average price of $15.82. Staples.com is creating a business-to-business electronic marketplace offering a comprehensive solution for all of the office needs of business customers. Staples Inc. has a market cap of $11.33 billion; its shares were traded at around $15.82 with a P/E ratio of 12.3 and P/S ratio of 0.5. The dividend yield of Staples Inc. stocks is 2.5%. Staples Inc. had an annual average earnings growth of 12.2% over the past 10 years. GuruFocus rated Staples Inc.the business predictability rank of 3-star.

On May 8, Staples Inc. announced the results for its first quarter ended April 30, 2011. Total company sales for the first quarter of 2011 increased two percent to $6.2 billion compared to the first quarter of 2010. Net income for the first quarter of 2011 increased five percent year over year to $198 million, and diluted earnings per share, on a GAAP basis, increased eight percent to $0.28 from $0.26 in the first quarter of 2010.

Staples Inc. is in the portfolios of Brian Rogers, David Dreman, Mario Gabelli, and Arnold Van Den Berg.

Last month, Buy: Director Robert E. Sulentic bought 15,150 shares of SPLS stock. Sell: Director Mary Elizabeth Burton sold 22,500 shares of Staples stock in April.

For the complete list of stocks that bought by their company executives, go to: Insider Buys.

Rating: 3.0/5 (8 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide